Free Trial

Xenon Pharmaceuticals (XENE) Insider Trading & Ownership

Xenon Pharmaceuticals logo
$34.90 -1.55 (-4.25%)
Closing price 04:00 PM Eastern
Extended Trading
$33.22 -1.68 (-4.81%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Xenon Pharmaceuticals (NASDAQ:XENE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.52%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$2.54 M
Get XENE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xenon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

XENE Insider Buying and Selling by Quarter

Remove Ads

Xenon Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/27/2025Ian MortimerCEOSell16,315$40.50$660,757.50  
1/24/2025Ian MortimerCEOSell22,468$40.20$903,213.60  
12/18/2024Sherry AulinCFOSell18,709$41.21$770,997.89  
11/22/2024Gary PatouDirectorSell4,891$41.08$200,922.28  
(Data available from 1/1/2013 forward)

XENE Insider Trading Activity - Frequently Asked Questions

5.52% of Xenon Pharmaceuticals stock is owned by insiders. Learn more on XENE's insider holdings.

The following insiders have sold XENE shares in the last 24 months: Dawn Svoronos ($967,500.00), Gary Patou ($648,042.48), Ian Mortimer ($2,874,804.65), Sherrington Robin ($330,300.36), Sherry Aulin ($770,997.89), Simon N Pimstone ($2,419,756.20), and Steven Gannon ($601,640.00).

Insiders have sold a total of 213,081 Xenon Pharmaceuticals shares in the last 24 months for a total of $8,613,041.58 sold.

Xenon Pharmaceuticals Key Executives



This page (NASDAQ:XENE) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners